Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1999 1
2004 2
2005 2
2008 2
2012 2
2013 2
2015 2
2016 5
2017 1
2018 4
2019 2
2020 5
2021 5
2022 2
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean lee h sang[Author] (190 results)?
Facioscapulohumeral Dystrophy.
Wang LH, Tawil R. Wang LH, et al. Curr Neurol Neurosci Rep. 2016 Jul;16(7):66. doi: 10.1007/s11910-016-0667-0. Curr Neurol Neurosci Rep. 2016. PMID: 27215221 Review.
Facioscapulohumeral Muscular Dystrophy.
Preston MK, Tawil R, Wang LH. Preston MK, et al. Among authors: wang lh. 1999 Mar 8 [updated 2020 Feb 6]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 1999 Mar 8 [updated 2020 Feb 6]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301616 Free Books & Documents. Review.
Current Therapeutic Approaches in FSHD.
Wang LH, Tawil R. Wang LH, et al. J Neuromuscul Dis. 2021;8(3):441-451. doi: 10.3233/JND-200554. J Neuromuscul Dis. 2021. PMID: 33579868 Free PMC article. Review.
A muscle strength enhancer for all seasons?
Wang LH, Weiss MD. Wang LH, et al. Muscle Nerve. 2018 May;57(5):697-698. doi: 10.1002/mus.26044. Epub 2018 Jan 30. Muscle Nerve. 2018. PMID: 29266321 No abstract available.
Molecular Therapies for Muscular Dystrophies.
Lin AY, Wang LH. Lin AY, et al. Among authors: wang lh. Curr Treat Options Neurol. 2018 Jun 21;20(7):27. doi: 10.1007/s11940-018-0509-2. Curr Treat Options Neurol. 2018. PMID: 29926204 Review.
Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophy.
Wang LH, Leung DG, Wagner KR, Lowry SJ, McDermott MP, Eichinger K, Higgs K, Walker M, Lewis L, Martens WB, Mul K, Sansone VA, Shieh P, Elsheikh B, LoRusso S, Butterfield RJ, Johnson N, Preston MR, Messina C, Carraro E, Tawil R, Statland J; ReSolve Investigators of the FSHD CTRN. Wang LH, et al. Neuromuscul Disord. 2023 Sep;33(9):63-68. doi: 10.1016/j.nmd.2023.06.008. Epub 2023 Jun 21. Neuromuscul Disord. 2023. PMID: 37400350
Correlations of disease severity outcome measures in inclusion body myositis.
Goyal NA, Greenberg SA, Cauchi J, Araujo N, Li V, Wencel M, Irani T, Wang LH, Palma AM, Villalta SA, Mozaffar T. Goyal NA, et al. Among authors: wang lh. Neuromuscul Disord. 2022 Oct;32(10):800-805. doi: 10.1016/j.nmd.2022.08.005. Epub 2022 Aug 24. Neuromuscul Disord. 2022. PMID: 36050251 Free PMC article.
Sleep Pathology in Creutzfeldt-Jakob Disease.
Kang P, de Bruin GS, Wang LH, Ward BA, Ances BM, Lim MM, Bucelli RC. Kang P, et al. Among authors: wang lh. J Clin Sleep Med. 2016 Jul 15;12(7):1033-9. doi: 10.5664/jcsm.5944. J Clin Sleep Med. 2016. PMID: 27250807 Free PMC article.
Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression.
Wong CJ, Friedman SD, Snider L, Bennett SR, Jones TI, Jones PL, Shaw DWW, Blemker SS, Riem L, DuCharme O, Lemmers RJFL, van der Maarel SM, Wang LH, Tawil R, Statland JM, Tapscott SJ. Wong CJ, et al. Among authors: wang lh. Hum Mol Genet. 2024 Apr 8;33(8):698-708. doi: 10.1093/hmg/ddae007. Hum Mol Genet. 2024. PMID: 38268317
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.
Tawil R, Wagner KR, Hamel JI, Leung DG, Statland JM, Wang LH, Genge A, Sacconi S, Lochmüller H, Reyes-Leiva D, Diaz-Manera J, Alonso-Perez J, Muelas N, Vilchez JJ, Pestronk A, Gibson S, Goyal NA, Hayward LJ, Johnson N, LoRusso S, Freimer M, Shieh PB, Subramony SH, van Engelen B, Kools J, Leinhard OD, Widholm P, Morabito C, Moxham CM, Cadavid D, Mellion ML, Odueyungbo A, Tracewell WG, Accorsi A, Ronco L, Gould RJ, Shoskes J, Rojas LA, Jiang JG. Tawil R, et al. Among authors: wang lh. Lancet Neurol. 2024 May;23(5):477-486. doi: 10.1016/S1474-4422(24)00073-5. Lancet Neurol. 2024. PMID: 38631764 Clinical Trial.
35 results